Has Robert Welliver, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,136 in general payments to Robert Welliver, MD across 55 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Welliver, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Welliver, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Welliver, MD

Urology · Albany, NYNPI 1124287651

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Coloplast at 51.5% of the total.

$3,136in general payments, 2019–2025

Across 55 payments — averaging $57.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Coloplast$2K
Boston Scientific$771
Olympus America Inc.$170
SRS Medical Systems, Inc.$119
Cook Medical LLC$114
Endo Pharmaceuticals Inc.$103
plus $242 from 9 others

$12,015in research payments, 2019–2025

Across 6 payments — averaging $2002.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Procept Biorobotics Corporation$12K

What the payments were for

Food & beverage$3,136100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Coloplast	23	$1,616
Boston Scientific	11	$771
Olympus America Inc.	2	$170
SRS Medical Systems, Inc.	2	$119
Cook Medical LLC	2	$114
Endo Pharmaceuticals Inc.	5	$103
Antares Pharma, Inc.	1	$50
Ferring Pharmaceuticals Inc.	1	$41
Blue Earth Diagnostics	2	$38
Endo USA, Inc.	1	$23
Rigicon,inc.	1	$23
Laborie Medical Technologies Corp.	1	$20
Urogen Pharma, Inc.	1	$17
Rochester Medical Corporation	1	$16
Provepharm Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,136 in reported general payments places this provider in the 55th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024

$60,660

Medicare patients

245

Services billed

4,317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	63	$56,496
Tamsulosin Hcl	302	$5,004
Finasteride	204	$2,727
Testosterone Cypionate	37	$2,359
Trospium Chloride ErTrospium Chloride	12	$1,797
Cabergoline	17	$1,604
Alfuzosin Hcl ErAlfuzosin Hcl	84	$1,549
Tamoxifen Citrate	45	$1,488
Oxybutynin Chloride ErOxybutynin Chloride	21	$524
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	14	$78
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	12	$56

Paid to pharmacies, not to this prescriber.

Other urology in Albany

Ronald KaufmanAlbany$173K
Brian MurrayAlbany$130K
Brian InouyeAlbany$57K
Peter WalterJamestown$1.9M
Christopher PieczonkaSyracuse$797K
Bilal ChughtaiNew York$658K
Katie MurrayNew York$575K
Neil BanderNew York$544K
Robert ValenzuelaNew York$494K
Jeffrey SpencerCheektowaga$430K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →